Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-006787

EVP and Chief Medical Officer sold 2,243 shares at $140.36 ($314,827)

From the SEC's structured data for this filing

Trades in this filing

Bedrosian Camille L · EVP and Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-01-30 Sale : show line 1 in the form −2,243 $140.36 $314,827 33,546 D
Open-market sales · 2,243 sh · avg $140.36 · $314,827
Loading xslF345X03/doc4.xml…